Executive screening.
نویسندگان
چکیده
منابع مشابه
Executive Stock Options as a Screening Mechanism
We study how and when option grants can be the optimal compensation to screen low-ability executives. In a dynamic setting, we consider the problem of a risk-neutral firm that tries to hire a risk-averse executive whose actions can affect the expected return and volatility of the stock price. Even if the optimal compensation for all types of executives is stock under complete information, it mi...
متن کاملScreening older adults for executive dysfunction.
Studies suggest that executive cognitive dysfunction can more reliably predict loss of autonomy than memory impairment can. Executive cognitive function allows for abstract thought, the planning and taking of actions toward a goal, and adaptation to the unexpected. And because executive function and memory operate in distinct regions of the brain, executive dysfunction can occur even when memor...
متن کاملThe executive interview as a screening test for executive dysfunction in patients with mild dementia.
OBJECTIVES To validate the Executive Interview (EXIT25) as a screening instrument for executive cognitive dysfunction in patients with mild dementia. DESIGN Validation using group comparison and correlation studies. SETTING The Copenhagen University Hospital Memory Clinic, a multidisciplinary outpatient clinic based in a neurological setting. PARTICIPANTS Thirty-three patients with mild d...
متن کاملScreening and Diagnosing Gestational Diabetes Mellitus Executive Summary
The Agency for Healthcare Research and Quality (AHRQ), through its Evidencebased Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist publicand private-sector organizations in their efforts to improve the quality of health care in the United States. The reports and assessments provide organizations with comprehensive, science-based informati...
متن کاملScreening for Methicillin-Resistant Staphylococcus Aureus (MRSA) Executive Summary
Methicillin-resistant Staphylococcus aureus (MRSA) emerged as a clinically relevant human pathogen more than five decades ago.1 The virulent bacterium was first detected in hospitals and other health care facilities where vulnerable hosts, frequent exposure to the selective pressure of intensive antimicrobial therapy, and the necessity for invasive procedures created a favorable environment for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1978
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.2.6147.1298-b